Funding has been allocated to support vaccine development. This investment aims to enhance preparedness for potential outbreaks. Deadly diseases such as Ebola and plague are among the targets of these projects.

The programme has previously contributed to the development of a COVID-19 vaccine. Its efforts now focus on strengthening the ability to rapidly develop and deploy vaccines. Further information on this initiative is available, including details on the specific diseases being targeted and the scope of the programme's work.